{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:55:03Z","timestamp":1791575703791,"version":"4.3.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AI129807"],"award-info":[{"award-number":["1R01AI129807"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2015 1288"],"award-info":[{"award-number":["PICT 2015 1288"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 11220150100145CO"],"award-info":[{"award-number":["PIP 11220150100145CO"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Resveratrol (RSV) is a multitarget drug that has demonstrated activity against\n                      <jats:italic>Toxoplasma gondii<\/jats:italic>\n                      in macrophage and human foreskin fibroblast (HFF) cell line infection models. However, the mechanism of action of RSV has not yet been determined. Thus, with the aim of identifying a possible mechanism of the anti-\n                      <jats:italic>T. gondii<\/jats:italic>\n                      activity of this compound, we analyzed the effects of RSV on histones H3 and H4 lysine 16 acetylation (H4K16). We also analyzed RSV-induced DNA damage to intracellular tachyzoites by using the DNA damage marker phosphorylated histone H2A.X (\u03b3H2AX).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      RSV inhibited intracellular\n                      <jats:italic>T. gondii<\/jats:italic>\n                      tachyzoite growth at concentrations below the toxic threshold for host cells. The IC\n                      <jats:sub>50<\/jats:sub>\n                      value after 24\u00a0h of treatment was 53 \u03bcM. RSV induced a reduction in H4K16 acetylation (H4K16ac), a marker associated with transcription, DNA replication and homologous recombination repair. A similar deacetylation effect was observed on histone H3. RSV also increased\n                      <jats:italic>T. gondii<\/jats:italic>\n                      H2A.X phosphorylation at the SQE motif (termed \u03b3H2A.X), which is a DNA damage-associated posttranslational modification. Our findings suggest a possible link between RSV and DNA damage or repair processes that is possibly associated with DNA replication stress.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13104-020-05416-4","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T15:10:28Z","timestamp":1610032228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Resveratrol induces H3 and H4K16 deacetylation and H2A.X phosphorylation in Toxoplasma gondii"],"prefix":"10.1186","volume":"14","author":[{"given":"Susana M.","family":"Contreras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustina","family":"Ganuza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda M.","family":"Corvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4871-3408","authenticated-orcid":false,"given":"Sergio O.","family":"Angel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"5416_CR1","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","volume":"30","author":"A Tenter","year":"2000","unstructured":"Tenter A, Heckeroth A, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30:1217\u201358. https:\/\/doi.org\/10.1016\/S0020-7519(00)00124-7.","journal-title":"Int J Parasitol"},{"key":"5416_CR2","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/J.IJPARA.2008.06.004","volume":"38","author":"MJ Gubbels","year":"2008","unstructured":"Gubbels MJ, White M, Szatanek T. The cell cycle and Toxoplasma gondii cell division: tightly knit or loosely stitched? Int J Parasitol. 2008;38:1343\u201358. https:\/\/doi.org\/10.1016\/J.IJPARA.2008.06.004.","journal-title":"Int J Parasitol"},{"key":"5416_CR3","doi-asserted-by":"publisher","first-page":"e00057-17","DOI":"10.1128\/CMR.00057-17","volume":"31","author":"IR Dunay","year":"2018","unstructured":"Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG. Treatment of Toxoplasmosis: historical Perspective, Animal Models, and Current Clinical Practice. Clin Microbiol Reviews. 2018;31:e00057-17. https:\/\/doi.org\/10.1128\/CMR.00057-17.","journal-title":"Clin Microbiol Reviews"},{"key":"5416_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fmicb.2017.00025","volume":"8","author":"M Montazeri","year":"2017","unstructured":"Montazeri M, Sharif M, Sarvi S, Mehrzadi S, Ahmadpour E, Daryani A. A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016). Front Microbiol. 2017;8:25. https:\/\/doi.org\/10.3389\/fmicb.2017.00025.","journal-title":"Front Microbiol"},{"key":"5416_CR5","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1586\/eri.12.100","volume":"10","author":"L Vanagas","year":"2012","unstructured":"Vanagas L, Jeffers V, Bogado SS, Dalmasso MC, Sullivan WJ, Angel SO. Toxoplasma histone acetylation remodelers as novel drug targets. Expert Rev Anti Infect Ther. 2012;10:1189\u2013201. https:\/\/doi.org\/10.1586\/eri.12.100.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"5416_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fcimb.2020.00289","volume":"10","author":"SO Angel","year":"2020","unstructured":"Angel SO, Vanagas L, Ruiz DM, Cristaldi C, Saldarriaga Cartagena AM, Sullivan WJ Jr. Emerging Therapeutic Targets against Toxoplasma gondii: update on DNA Repair Response Inhibitors and Genotoxic Drugs. Front Cell Infect Microbiol. 2020;10:289. https:\/\/doi.org\/10.3389\/fcimb.2020.00289.","journal-title":"Front Cell Infect Microbiol"},{"key":"5416_CR7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2174\/138161207780162836","volume":"13","author":"MH el Kouni","year":"2007","unstructured":"el Kouni MH. Adenosine metabolism in Toxoplasma gondii: potential targets for chemotherapy. Curr Pharm Des. 2007;13:581\u201397. https:\/\/doi.org\/10.2174\/138161207780162836.","journal-title":"Curr Pharm Des"},{"key":"5416_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.molcel.2004.08.031","volume":"16","author":"A Vaquero","year":"2004","unstructured":"Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P, Reinberg D. Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell. 2004;16:93\u2013105. https:\/\/doi.org\/10.1016\/j.molcel.2004.08.031PMID: 15469825.","journal-title":"Mol Cell"},{"key":"5416_CR9","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1038\/sj.onc.1210617","volume":"26","author":"A Vaquero","year":"2007","unstructured":"Vaquero A, Sternglanz R, Reinberg D. NAD \u00fe-dependent deacetylation of H4 lysine 16 by class III HDACs. Oncogene. 2007;26:5505\u201320. https:\/\/doi.org\/10.1038\/sj.onc.1210617.","journal-title":"Oncogene"},{"key":"5416_CR10","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.3390\/ijms21062084","volume":"21","author":"A Shaito","year":"2020","unstructured":"Shaito A, Posadino AM, Younes N, Hasan H, Halabi S, Alhababi D, Al-Mohannadi A, Abdel-Rahman WM, Eid AH, Nasrallah GK, Pintus G. Potential Adverse Effects of Resveratrol: a Literature Review. Int J Mol Sci. 2020;21:2084. https:\/\/doi.org\/10.3390\/ijms21062084.","journal-title":"Int J Mol Sci"},{"key":"5416_CR11","doi-asserted-by":"publisher","first-page":"e0219317","DOI":"10.1371\/journal.pone.0219317","volume":"14","author":"K-Y Chen","year":"2019","unstructured":"Chen K-Y, Chen C-C, Chang Y-C, Chang M-C. Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9. PLoS ONE. 2019;14:e0219317. https:\/\/doi.org\/10.1371\/journal.pone.0219317.","journal-title":"PLoS ONE"},{"key":"5416_CR12","doi-asserted-by":"publisher","unstructured":"Bereswill S, Mu\u00f1oz\u00a0M, Fischer A, Plickert R, Haag LM, Otto B. et al. Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS One. 2010; 5: e15099. https:\/\/doi.org\/10.1371\/journal.pone.0015099.","DOI":"10.1371\/journal.pone.0015099"},{"key":"5416_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.micpath.2015.07.013","volume":"87","author":"NB Bottari","year":"2015","unstructured":"Bottari NB, Baldissera MD, Tonin AA, Rech VC, Nishihira VS, Thom\u00e9 GR, et al. Effects of sulfamethoxazole-trimethoprim associated to resveratrol on its free form and complexed with 2-hydroxypropyl-\u03b2-cyclodextrin on cytokines levels of mice infected by Toxoplasma gondii. Microb Pathog. 2015;87:40\u20134. https:\/\/doi.org\/10.1016\/j.micpath.2015.07.013.","journal-title":"Microb Pathog"},{"key":"5416_CR14","doi-asserted-by":"publisher","first-page":"e01233-18","DOI":"10.1128\/AAC.01233-18","volume":"63","author":"QW Chen","year":"2019","unstructured":"Chen QW, Dong K, Qin HX, Yang YK, He JL, Li J, et al. The direct and indirect inhibition effects of resveratrol against Toxoplasma gondii tachyzoites in vitro. Antimicrob Agents Chemother. 2019;63:e01233-18. https:\/\/doi.org\/10.1128\/AAC.01233-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"5416_CR15","first-page":"369","volume":"92","author":"OS Adeyemi","year":"2019","unstructured":"Adeyemi OS, Atolani O, Awakan OJ, Olaolu TD, Nwonuma CO, Alejolowo O, et al. In Vitro Screening to Identify Anti-Toxoplasma compounds and in silico modeling for bioactivities and toxicity. Yale J Biol Med. 2019;92:369\u201383 PMID: 31543702.","journal-title":"Yale J Biol Med."},{"key":"5416_CR16","doi-asserted-by":"publisher","unstructured":"Bogado SS, Dalmasso C, Ganuza A, Kim K, Sullivan WJ Jr, Angel SO, Vanagas L. Canonical histone H2Ba and H2A.X dimerize in an opposite genomic localization to H2A.Z\/H2B.Z dimers in Toxoplasma gondii. Molecular and Biochemical Parasitology 197: 36-42. https:\/\/doi.org\/10.1016\/j.molbiopara.2014.09.009.","DOI":"10.1016\/j.molbiopara.2014.09.009"},{"key":"5416_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13071-019-3362-6","volume":"12","author":"E S\u00e1nchez-L\u00f3pez","year":"2019","unstructured":"S\u00e1nchez-L\u00f3pez E, Corigliano M, Albarrac\u00edn R, Sander VA, Legarralde A, Bengoa-Luoni SA, et al. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide. Parasit Vectors. 2019;12:140. https:\/\/doi.org\/10.1186\/s13071-019-3362-6.","journal-title":"Parasit Vectors."},{"key":"5416_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fcimb.2019.00026","volume":"9","author":"J Munera L\u00f3pez","year":"2019","unstructured":"Munera L\u00f3pez J, Ganuza A, Bogado SS, et al. Evaluation of ATM Kinase Inhibitor KU-55933 as Potential Anti-Toxoplasma gondii Agent. Front. Cell. Infect. Microbiol. 2019;9:26. https:\/\/doi.org\/10.3389\/fcimb.2019.00026.","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"5416_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijpddr.2016.12.003","volume":"7","author":"VA Campo","year":"2017","unstructured":"Campo VA. Comparative effects of histone deacetylases inhibitors and resveratrol on Trypanosoma cruzi replication, differentiation, infectivity and gene expression. Int J Parasitol Drugs Drug Resist. 2017;7:23\u201333. https:\/\/doi.org\/10.1016\/j.ijpddr.2016.12.003.","journal-title":"Int J Parasitol Drugs Drug Resist."},{"key":"5416_CR20","doi-asserted-by":"publisher","first-page":"5544","DOI":"10.3892\/mmr.2016.5942","volume":"14","author":"G-D Chen","year":"2016","unstructured":"Chen G-D, Yu W-D, Chen X-P. SirT1 activator represses the transcription of TNF-\u03b1 in THP-1 cells of a sepsis model via deacetylation of H4K16. Mol Med Rep. 2016;14:5544\u201350. https:\/\/doi.org\/10.3892\/mmr.2016.5942.","journal-title":"Mol Med Rep."},{"key":"5416_CR21","doi-asserted-by":"publisher","first-page":"e1007418","DOI":"10.1371\/journal.pgen.1007418","volume":"14","author":"TA Hoggard","year":"2018","unstructured":"Hoggard TA, Chang F, Perry KR, Subramanian S, Kenworthy J, Chueng J, et al. Yeast heterochromatin regulators Sir2 and Sir3 act directly at euchromatic DNA replication origins. PLoS Genet. 2018;14:e1007418. https:\/\/doi.org\/10.1371\/journal.pgen.1007418.","journal-title":"PLoS Genet"},{"key":"5416_CR22","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.1158\/1078-0432.CCR-11-1072","volume":"17","author":"A Tyagi","year":"2011","unstructured":"Tyagi A, Gu M, Takahata T, Frederick B, Agarwal C, Siriwardana S, et al. Resveratrol selectively induces DNA damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma. Clin Cancer Res. 2011;17:5402\u201311. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1072.","journal-title":"Clin Cancer Res"},{"key":"5416_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s42003-019-0498-z","volume":"2","author":"N Horikoshi","year":"2019","unstructured":"Horikoshi N, Sharma D, Leonard F, Pandita RJ, Charaka VK, Hambarde S, et al. Pre-existing H4K16ac levels in euchromatin drive DNA repair by homologous recombination in S-phase. Commun Biol. 2019;2:253. https:\/\/doi.org\/10.1038\/s42003-019-0498-z.","journal-title":"Commun Biol."},{"key":"5416_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.dnarep.2015.04.026","volume":"32","author":"D Cortez","year":"2015","unstructured":"Cortez D. Preventing replication fork collapse to maintain genome integrity. DNA Repair. 2015;32:149\u201357. https:\/\/doi.org\/10.1016\/j.dnarep.2015.04.026.","journal-title":"DNA Repair"},{"key":"5416_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrm2351","volume":"9","author":"D Branzei","year":"2008","unstructured":"Branzei D, Foiani M. Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol. 2008;9:297\u2013308. https:\/\/doi.org\/10.1038\/nrm2351.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5416_CR26","doi-asserted-by":"publisher","first-page":"e49761","DOI":"10.1371\/journal.pone.0049761","volume":"7","author":"M Gertz","year":"2012","unstructured":"Gertz M, Nguyen GT, Fischer F, Suenkel B, Schlicker C, et al. A molecular mechanism for direct sirtuin activation by resveratrol. PLoS ONE. 2012;7:e49761. https:\/\/doi.org\/10.1371\/journal.pone.0049761.","journal-title":"PLoS ONE"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05416-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-020-05416-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05416-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T15:32:07Z","timestamp":1610033527000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-020-05416-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5416"],"URL":"https:\/\/doi.org\/10.1186\/s13104-020-05416-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.25.266031","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-94395\/v1","asserted-by":"object"}]},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"8 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interests exist.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}